These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2266641)

  • 41. Reversible agranulocytosis related to azidothymidine therapy.
    Goldsmith JC; Irvine W
    Am J Hematol; 1989 Apr; 30(4):263-4. PubMed ID: 2929589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zidovudine treatment of AIDS and ARC in Denmark 1987.
    Teglbjaerg LL; Mathiesen LR; Søeberg B; Nielsen L; Thorsen B; Buhl M; Pedersen C; Bonnevie O; Nielsen C; Vestergaard BF
    Scand J Infect Dis; 1989; 21(4):367-73. PubMed ID: 2685984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Zidovudine in asymptomatic HIV infection: knowledge and uncertainty.
    Pinching AJ
    Int J STD AIDS; 1991; 2(3):157-61. PubMed ID: 1863644
    [No Abstract]   [Full Text] [Related]  

  • 44. Risk management in transfusion medicine. The AIDS era underscores the need for a unified, comprehensive risk management program for all aspects of transfusion--from donor selection to post-transfusion outcomes.
    Berte LM; Dechristopher PJ
    MLO Med Lab Obs; 1996 Mar; 28(3):28-34. PubMed ID: 10156309
    [No Abstract]   [Full Text] [Related]  

  • 45. [AIDS: AZT gets the green light in Ottawa].
    Nurs Que; 1991; 11(2):47. PubMed ID: 2027604
    [No Abstract]   [Full Text] [Related]  

  • 46. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zidovudine--AZT.
    Manser A
    Aust Nurses J; 1989 Apr; 18(9):37. PubMed ID: 2712762
    [No Abstract]   [Full Text] [Related]  

  • 48. The drugs 2',3'-dideoxyinosine (ddI) and 2',3'-dideoxycytidine (ddC) are safe alternatives in people with AIDS with zidovudine-induced myopathy.
    Jay C; Ropka M; Dalakas MC
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):630-1. PubMed ID: 8176648
    [No Abstract]   [Full Text] [Related]  

  • 49. Observations concerning the use of zidovudine in an outpatient setting.
    Skelton WP; Skelton NK
    Arch Intern Med; 1991 Jun; 151(6):1238-9. PubMed ID: 2043033
    [No Abstract]   [Full Text] [Related]  

  • 50. Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Langtry HD; Campoli-Richards DM
    Drugs; 1989 Apr; 37(4):408-50. PubMed ID: 2661194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AZT for children with AIDS.
    Engel NS
    MCN Am J Matern Child Nurs; 1989; 14(2):121. PubMed ID: 2495409
    [No Abstract]   [Full Text] [Related]  

  • 52. Zidovudine and other drugs against HIV.
    Drug Ther Bull; 1988 Dec; 26(26):101-4. PubMed ID: 3065024
    [No Abstract]   [Full Text] [Related]  

  • 53. Zidovudine experience at the Hospitals for Sick Children, Great Ormond Street, London.
    Ball LM
    J Infect; 1989 Jan; 18 Suppl 1():83. PubMed ID: 2915142
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical experience with zidovudine in patients with acquired immunodeficiency syndrome. Analysis of 117 cases. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas].
    Biedma D; Bascuñana A; Viciana P; Causse M; Torres Tortosa M; Lozano de León F; Pujol E; Pachón J
    Rev Clin Esp; 1992 Sep; 191(4):187-92. PubMed ID: 1439038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Zidovudine therapy in an inner city population.
    Samuels JE; Hendrix J; Hilton M; Marantz PR; Sloan V; Small CB
    J Acquir Immune Defic Syndr (1988); 1990; 3(9):877-83. PubMed ID: 2384864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.
    McKinney RE; Pizzo PA; Scott GB; Parks WP; Maha MA; Lehrman SN; Riggs M; Eddy J; Lane BA; Eppes SC
    J Pediatr; 1990 Apr; 116(4):640-7. PubMed ID: 2181102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic.
    Samet JH; Libman H; Steger KA; Dhawan RK; Chen J; Shevitz AH; Dewees-Dunk R; Levenson S; Kufe D; Craven DE
    Am J Med; 1992 May; 92(5):495-502. PubMed ID: 1580296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AIDS: AZT for children in extended US trial.
    Lindley D
    Nature; 1989 Nov; 342(6245):10. PubMed ID: 2811993
    [No Abstract]   [Full Text] [Related]  

  • 59. Early HIV infection: to treat or not to treat?
    Swart AM; Weller I; Darbyshire JH
    BMJ; 1990 Oct; 301(6756):825-6. PubMed ID: 2282416
    [No Abstract]   [Full Text] [Related]  

  • 60. Recombinant human erythropoietin in the treatment of anemia in AIDS patients receiving concomitant amphotericin B and zidovudine.
    Lancaster DJ; Palte S; Ray D
    J Acquir Immune Defic Syndr (1988); 1993 May; 6(5):533-4. PubMed ID: 8483118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.